Skip to main content
SpringerLink
Log in

Personalize protocols when deprescribing psychotropics used to manage behavioural changes in individuals with dementia

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

When managing behavioural changes in individuals with dementia in long-term care settings, non-pharmacological approaches should be the first-line option. However, evidence indicates that psychotropic medications are prescribed excessively in this patient population. Psychotropics can be successfully deprescribed by gradually withdrawing treatment, by taking a person-centred approach that actively involves residents, their family/support persons and multidisciplinary teams, by ensuring healthcare staff are well trained and supported by management, and by employing effective communication strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Harrison SL, Cations M, Jessop T, et al. Approaches to deprescribing psychotropic medications for changed behaviours in long-term care residents living with dementia. Drugs Aging. 2019;36(2):125–36.

    Article  PubMed  Google Scholar 

  2. Westbury J, Gee P, Ling T, et al. More action needed: psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry. 2019;53(2):135–47.

    Article  Google Scholar 

  3. Zhao Q-F, Tan L, Wang HF, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264–71.

    Article  PubMed  Google Scholar 

  4. Nørgaard A, Jensen-Dahm C, Gasse C, et al. Psychotropic polypharmacy in patients with dementia: prevalence and predictors. J Alzheimers Dis. 2017;56(2):707–16.

    Article  PubMed  Google Scholar 

  5. Banerjee S. The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services United Kingdom Department of Health. London: Department of Health & Social Care; 2009.

    Google Scholar 

  6. Declercq T, Petrovic M, Azermai M, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;4:CD007726.

    Google Scholar 

  7. Tampi RR, Tampi DJ, Balachandran S, et al. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis. 2016;7(5):229–45.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Laver K, Cumming RG, Dyer SM, et al. Clinical practice guidelines for dementia in Australia. Med J Aust. 2016;204(5):191–3.

    Article  PubMed  Google Scholar 

  9. Buterbaugh WM, Jamrose T, Lazzara J, et al. Review of antidepressants in the treatment of behavioral and psychiatric symptoms in dementia (BPSD). Ment Health Clin. 2014;4(4):183–8.

    Article  Google Scholar 

  10. Rosenberg PB, Martin BK, Frangakis C, et al. Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry. 2010;18(2):136–45.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Banerjee S, Hellier J, Dewey M, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378(9789):403–11.

    Article  CAS  PubMed  Google Scholar 

  12. Defrancesco M, Marksteiner J, Fleischhacker WW, et al. Use of benzodiazepines in Alzheimer’s disease: a systematic review of literature. Int J Neuropsychopharmacol. 2015;18(10):pvy055.

    Article  CAS  Google Scholar 

  13. Tible OP, Riese F, Savaskan E, et al. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord. 2017;10(8):297–309.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Dyer SM, Harrison SL, Laver K, et al. An overview of systematic reviews of pharmacological and nonpharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2018;30(3):295–309.

    Article  PubMed  Google Scholar 

  15. Orgeta V, Qazi A, Spector A, et al. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis. Br J Psychiatry. 2015;207(4):293–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Plakiotis C, Bell JS, Jeon YH, et al. Deprescribing psychotropic medications in aged care facilities: the potential role of family members. Adv Exp Med Biol. 2015;821:29–43.

    Article  PubMed  Google Scholar 

  17. Brodaty H, Aerts L, Harrison F, et al. Antipsychotic deprescription for older adults in long-term care: the HALT study. J Am Med Dir Assoc. 2018;19(7):592–600.e7.

    Article  PubMed  Google Scholar 

  18. Royal Australian & New Zealand College of Psychiatrists. Antipsychotic medications as a treatment of behavioural and psychological symptoms of dementia. Melbourne: Royal Australian & New Zealand College of Psychiatrists; 2016.

    Google Scholar 

  19. Alldred DP, Kennedy MC, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:Cd009095.

    PubMed  Google Scholar 

  20. Fossey J, Ballard C, Juszczak E, et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ. 2006;332(7544):756–61.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Jennings AA, Foley T, Walsh KA, et al. General practitioners’ knowledge, attitudes, and experiences of managing behavioural and psychological symptoms of dementia: a mixed-methods systematic review. Int J Geriatr Psychiatry. 2018;7(1):62.

    Google Scholar 

  22. Chenoweth L, Forbes I, Fleming R, et al. PerCEN: a cluster randomized controlled trial of person-centered residential care and environment for people with dementia. Int Psychogeriatr. 2014;26(7):1147–60.

    Article  PubMed  Google Scholar 

  23. Barry MJ, Edgman-Levitan S. Shared decision making—pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–1.

    Article  CAS  PubMed  Google Scholar 

  24. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Turner JP, Edwards S, Stanners M, et al. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ Open. 2016;6(3):e009781.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Jansen J, Naganathan V, Carter SM, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353:i2893.

    Article  PubMed  Google Scholar 

  27. Rendina N, Brodaty H, Draper B, et al. Substitute consent for nursing home residents prescribed psychotropic medication. Int J Geriatr Psychiatry. 2009;24(3):226–31.

    Article  PubMed  Google Scholar 

  28. Sawan M, Jeon YH, Fois RA, et al. Exploring the link between organizational climate and the use of psychotropic medicines in nursing homes: a qualitative study. Res Soc Adm Pharm. 2017;13(3):513–23.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Ethics declarations

    Conflict of interest

    The article was adapted from Drugs & Aging (2019) 36(2):125–36 [1] by employees of Adis International Ltd./Springer Nature, who are responsible for the article content and declare no conflicts of interest.

    Funding

    The preparation of this review was not supported by any external funding.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Personalize protocols when deprescribing psychotropics used to manage behavioural changes in individuals with dementia. Drugs Ther Perspect 35, 424–428 (2019). https://doi.org/10.1007/s40267-019-00655-3

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-019-00655-3

    Search

    Navigation